These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6182259)

  • 1. [Phase III study of cisplatin on gynecological malignancy].
    Chen JT; Takizawa K; Kawana T; Kawagoe K; Yoshida R; Yoshikawa H; Mizuno M; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):710-9. PubMed ID: 6182259
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
    Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
    Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).
    Hainsworth JD; Burnett LS; Jones HW; Greco FA
    Cancer Treat Rep; 1983 Apr; 67(4):393-5. PubMed ID: 6189602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D
    Clin Obstet Gynaecol; 1978 Dec; 5(3):709-27. PubMed ID: 367674
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
    Levin L; Hryniuk W
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern chemotherapy of a malignant testicular tumors (author's transl)].
    Arnold H; Fiebig HH
    Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
    Ehrlich CE; Einhorn L; Williams SD; Morgan J
    Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.